Skip to main content
Caplight Logo









BioSort

BioSort

Private
NorwayFrontier & Industrial Techhttps://biosort.no/

Last Round

Early Funding

Feb 23, 2026

Total Funding Raised

$10.44M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

BioSort is an aquaculture technology company that develops sensor-based equipment and AI-driven solutions to monitor fish health and improve sustainability in the aquaculture industry.

Sector

Frontier & Industrial Tech

Verticals

Environmental Monitoring, Sensors, Computer Vision

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

aquaculture technologyprecision fish farmingfish health monitoringsea lice managementcomputer visionautomated fish sortingaquatechsmart farmingfish welfareartificial intelligenceagtechsensor-based systemsindividual fish trackingfishIDaquaculture hardwareSaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioSort Comparables

Compare BioSort with similar companies based on industry and business-model similarity.

BioSort comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fishency Innovation AS
90%
Stingray Marine Solutions
86%
OptoScale AS
79%

BioSort Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingFeb 23, 2026

Key People

Founding team and executive leadership

Geir Stang Hauge

CEO

Executive Team

Avinash Burla

Chief Technology Officer

Executive Team

BioSort Investors

Notable investors and investment history

BioSort investors
InvestorRounds
Ichthus Venture CapitalEarly Funding
Grieg KapitalEarly Funding
FarvatnEarly Funding
Futurum VenturesEarly Funding
Hatch BlueEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 20, 2026

    Monthly visitors grew 775% MoM to 3.2K.

  • Feb 24, 2026

    Launched new sea lice control technology, funded by NOK 100M+ raise.

BioSort Filings

Explore SEC and related filing metadata, where available.

BioSort filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BioSort's valuation, stock price, and market status.

Is BioSort a public or private company?

BioSort is a private company.

What is the current stock price of BioSort?

BioSort is a private company with no public stock price. No recent secondary market data is available.

How much is BioSort worth (valuation)?

Valuation information for BioSort is not publicly available.

Can I buy BioSort stock?

BioSort shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BioSort's last funding round?

BioSort's most recent funding round was Early Funding on February 24, 2026.

Who are the main investors in BioSort?

Key investors in BioSort include Ichthus Venture Capital, Grieg Kapital, Farvatn, Futurum Ventures, Hatch Blue.

Will BioSort IPO soon?

No public IPO plans have been announced for BioSort.

How can I track BioSort secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioSort's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNorway
Employee Range19
Year Founded2010
Last FundingFeb 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?